FDA Grants First Approval to First-Line Therapy for Advanced Anal Cancer

(MedPage Today)-The Food and Drug Administration (FDA) gave the first approval to treat the first line of anal cancer of the PD-1 Retifanimab (Zynyz), the agency announced on Thursday. Approval of its use with carbplatin and Bacltaxel …